The Search for Mutations in Myeloproliferative Neoplasms

This journal article reviews the roles of known mutations in primary myelofibrosis, polycythemia vera, essential thrombocythemia, and unclassified MPNs—including JAK2, CALR, and MPL—and discusses data from a recent sequencing study focused on the prevalence of SF3B1 mutations among patients with BCR-ABL1-negative MPNs.

Oncology Times